Unveiling Niche Experts: Elevating Biopharma’s Impact Through Specialized Knowledge
In the dynamic landscape of the biopharma industry, where innovation and clinical expertise must converge, it’s not just the well-known […]
Enhancing Your Market Access Influence Network: The Vital Role of Key Opinion Leaders (KOLs) in Navigating Integrated Delivery Networks (IDNs) and Payer Organizations
In the ever-evolving landscape of the pharmaceutical industry, market access has become a critical factor in the success of new
Empowering Your Influence Strategy: Leveraging Key Opinion Leaders (KOLs) and Their Networks to Engage Regional Key Decision Makers
In the fiercely competitive pharmaceutical industry, an effective influence strategy is paramount for achieving market access and commercial success. Regional
Harnessing the Orbital Theory of Influence to Optimize an Advisory Board
Introduction Relationships are the key to success, and building a strong network of advisors can be the difference between a
The Evolution of Pharma Marketing: KOL Mapping and Sentiment Analysis in the 21st Century
In today’s dynamic healthcare landscape, relying solely on syndicated Key Opinion Leader (KOL) databases is no longer sufficient for pharmaceutical
Comparing KOLs and DOLs Influence in Pharma
Due to the rapidly changing landscape of the pharmaceutical industry, maximizing influence within the market remains of utmost importance. Both
Introducing Neolytica: QPharma’s New AI-Powered Healthcare Analytics Firm
QPharma Launches Neolytica, an AI-Focused Healthcare Analytics Firm Driving Data-Driven Decision-Making in the Life Sciences Industry Morristown, NJ – March
QPharma’s Neolytica Experiences Explosive Business Growth
Neolytica Experiences Explosive Business Growth Morristown, NJ – March 17, 2022 – Neolytica, a healthcare analytics firm, today announced that
The AI Journal Interview: Badal Shah, Managing Director at Neolytica – Your Health Analytics Partner
The article features an interview with Badal Shah, the Managing Director at Neolytica, a subsidiary of QPharma. Shah discusses how
